Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sight Sciences, Inc. (SGHT) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sight Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1531177.
Total stock buying since 2021: $51,595,689.
Total stock sales since 2021: $20,767,799.
Total stock option exercises since 2021: $216,929.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 337,496 | $1,263,367 | 212,795 | $684,988 | 40,000 | $4,800 |
| 2024 | 566,802 | $2,116,443 | 781,410 | $3,369,881 | 0 | $0 |
| 2023 | 985,116 | $2,993,719 | 2,852,036 | $16,712,930 | 187,668 | $90,329 |
| 2022 | 556,802 | $4,639,531 | 0 | $0 | 210,332 | $121,800 |
| 2021 | 1,762,048 | $40,582,629 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 62,625 | $259,039 | 40,000 | $4,800 |
| 2025-06 | 146,554 | $601,482 | 0 | $0 | 0 | $0 |
| 2025-05 | 170,942 | $608,635 | 13,066 | $45,430 | 0 | $0 |
| 2025-04 | 0 | $0 | 63,988 | $147,564 | 0 | $0 |
| 2025-03 | 20,000 | $53,250 | 0 | $0 | 0 | $0 |
| 2025-01 | 0 | $0 | 73,116 | $232,955 | 0 | $0 |
| 2024-12 | 8,376 | $32,382 | 0 | $0 | 0 | $0 |
| 2024-11 | 558,426 | $2,084,061 | 551,802 | $2,058,221 | 0 | $0 |
| 2024-10 | 0 | $0 | 118,327 | $696,855 | 0 | $0 |
| 2024-07 | 0 | $0 | 34,774 | $219,232 | 0 | $0 |
| 2024-05 | 0 | $0 | 13,066 | $70,869 | 0 | $0 |
| 2024-04 | 0 | $0 | 34,129 | $173,339 | 0 | $0 |
| 2024-01 | 0 | $0 | 29,312 | $151,365 | 0 | $0 |
| 2023-12 | 0 | $0 | 2,852,036 | $16,712,930 | 0 | $0 |
| 2023-11 | 985,116 | $2,993,719 | 0 | $0 | 150,000 | $16,500 |
| 2023-09 | 0 | $0 | 0 | $0 | 37,668 | $73,829 |
| 2022-09 | 0 | $0 | 0 | $0 | 40,000 | $9,200 |
| 2022-05 | 556,802 | $4,639,531 | 0 | $0 | 150,000 | $72,750 |
| 2022-03 | 0 | $0 | 0 | $0 | 3,666 | $7,185 |
| 2022-02 | 0 | $0 | 0 | $0 | 16,666 | $32,665 |
| 2021-12 | 214,606 | $4,772,193 | 0 | $0 | 0 | $0 |
| 2021-11 | 320,394 | $6,361,284 | 0 | $0 | 0 | $0 |
| 2021-10 | 527,048 | $12,649,152 | 0 | $0 | 0 | $0 |
| 2021-07 | 700,000 | $16,800,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-17 | Badawi David (Chief Technology Officer) | Option Ex | 40,000 | .12 | 4,800 |
| 2025-07-03 | Badawi David (Chief Technology Officer) | Sale | 5,679 | 4.17 | 23,704 |
| 2025-07-03 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 9,160 | 4.17 | 38,233 |
| 2025-07-02 | Bauerlein Alison (Chief Financial Officer) | Sale | 19,260 | 4.10 | 78,927 |
| 2025-07-02 | Link Matthew (Chief Commercial Officer) | Sale | 4,889 | 4.10 | 20,035 |
| 2025-07-01 | Badawi Paul (President and CEO) | Sale | 23,637 | 4.15 | 98,140 |
| 2025-06-06 | Encrantz Staffan | Buy | 27,900 | 4.22 | 117,738 |
| 2025-06-05 | Encrantz Staffan | Buy | 40,951 | 4.24 | 173,796 |
| 2025-06-04 | Encrantz Staffan | Buy | 21,674 | 4.17 | 90,423 |
| 2025-06-03 | Encrantz Staffan | Buy | 25,230 | 3.97 | 100,087 |
| 2025-06-02 | Encrantz Staffan | Buy | 30,799 | 3.88 | 119,438 |
| 2025-05-30 | Encrantz Staffan | Buy | 42,753 | 3.67 | 156,903 |
| 2025-05-29 | Encrantz Staffan | Buy | 60,128 | 3.59 | 215,739 |
| 2025-05-28 | Encrantz Staffan | Buy | 26,715 | 3.52 | 93,929 |
| 2025-05-27 | Encrantz Staffan | Buy | 41,346 | 3.44 | 142,064 |
| 2025-05-19 | Bauerlein Alison (Chief Financial Officer) | Sale | 13,066 | 3.48 | 45,430 |
| 2025-04-02 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 9,395 | 2.31 | 21,693 |
| 2025-04-02 | Bauerlein Alison (Chief Financial Officer) | Sale | 19,397 | 2.31 | 44,787 |
| 2025-04-02 | Link Matthew (Chief Commercial Officer) | Sale | 5,042 | 2.31 | 11,641 |
| 2025-04-01 | Badawi Paul (President and CEO) | Sale | 24,174 | 2.30 | 55,672 |
| 2025-04-01 | Badawi David (Chief Technology Officer) | Sale | 5,980 | 2.30 | 13,771 |
| 2025-03-13 | Raheja Manohar K. (EVP, Research & Development) | Buy | 10,000 | 2.60 | 26,000 |
| 2025-03-12 | Raheja Manohar K. (EVP, Research & Development) | Buy | 10,000 | 2.73 | 27,250 |
| 2025-01-17 | Badawi David (Chief Technology Officer) | Sale | 5,423 | 2.78 | 15,081 |
| 2025-01-17 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 6,922 | 2.78 | 19,250 |
| 2025-01-16 | Badawi Paul (President and CEO) | Sale | 24,819 | 2.92 | 72,570 |
| 2025-01-08 | Badawi David (Chief Technology Officer) | Sale | 3,829 | 3.26 | 12,478 |
| 2025-01-08 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 1,810 | 3.26 | 5,898 |
| 2025-01-03 | Badawi David (Chief Technology Officer) | Sale | 3,111 | 3.52 | 10,956 |
| 2025-01-03 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 4,864 | 3.52 | 17,131 |
| 2025-01-03 | Bauerlein Alison (Chief Financial Officer) | Sale | 10,102 | 3.52 | 35,579 |
| 2025-01-02 | Badawi Paul (President and CEO) | Sale | 12,236 | 3.60 | 44,012 |
| 2024-12-06 | Raheja Manohar K. (EVP, Research & Development) | Buy | 5,000 | 3.85 | 19,250 |
| 2024-12-03 | Raheja Manohar K. (EVP, Research & Development) | Buy | 3,376 | 3.89 | 13,132 |
| 2024-11-29 | Raheja Manohar K. (EVP, Research & Development) | Buy | 4,624 | 3.99 | 18,440 |
| 2024-11-21 | Encrantz Staffan | Buy | 551,802 | 3.73 | 2,058,221 |
| 2024-11-21 | Encrantz Staffan | Sale | 551,802 | 3.73 | 2,058,221 |
| 2024-11-19 | Raheja Manohar K. (EVP, Research & Development) | Buy | 2,000 | 3.70 | 7,400 |
| 2024-10-21 | Link Matthew (Chief Commercial Officer) | Sale | 21,831 | 5.61 | 122,450 |
| 2024-10-18 | Link Matthew (Chief Commercial Officer) | Sale | 20,487 | 5.98 | 122,450 |
| 2024-10-17 | Link Matthew (Chief Commercial Officer) | Sale | 20,970 | 5.84 | 122,443 |
| 2024-10-16 | Link Matthew (Chief Commercial Officer) | Sale | 20,734 | 5.91 | 122,434 |
| 2024-10-02 | Badawi Paul (President and CEO) | Sale | 12,727 | 5.99 | 76,183 |
| 2024-10-02 | Badawi David (Chief Technology Officer) | Sale | 3,167 | 5.99 | 18,957 |
| 2024-10-01 | Park Sam Boong (Chief Operating Officer) | Sale | 3,403 | 6.08 | 20,690 |
| 2024-10-01 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 4,878 | 6.08 | 29,658 |
| 2024-10-01 | Bauerlein Alison (Chief Financial Officer) | Sale | 10,130 | 6.08 | 61,590 |
| 2024-07-02 | Park Sam Boong (Chief Operating Officer) | Sale | 3,525 | 6.21 | 21,897 |
| 2024-07-02 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 5,055 | 6.21 | 31,401 |
| 2024-07-02 | Bauerlein Alison (Chief Financial Officer) | Sale | 10,497 | 6.21 | 65,207 |
| 2024-07-01 | Badawi Paul (President and CEO) | Sale | 12,569 | 6.42 | 80,655 |
| 2024-07-01 | Badawi David (Chief Technology Officer) | Sale | 3,128 | 6.42 | 20,072 |
| 2024-05-17 | Bauerlein Alison (Chief Financial Officer) | Sale | 13,066 | 5.42 | 70,869 |
| 2024-04-03 | Park Sam Boong (Chief Operating Officer) | Sale | 3,414 | 5.08 | 17,339 |
| 2024-04-03 | Badawi Paul (President and CEO) | Sale | 12,571 | 5.08 | 63,848 |
| 2024-04-03 | Badawi David (Chief Technology Officer) | Sale | 3,128 | 5.08 | 15,887 |
| 2024-04-03 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 4,893 | 5.08 | 24,851 |
| 2024-04-03 | Bauerlein Alison (Chief Financial Officer) | Sale | 10,123 | 5.08 | 51,414 |
| 2024-01-17 | Park Sam Boong (Chief Operating Officer) | Sale | 5,443 | 5.16 | 28,107 |
| 2024-01-17 | Badawi Paul (President and CEO) | Sale | 15,917 | 5.16 | 82,195 |
| 2024-01-17 | Badawi David (Chief Technology Officer) | Sale | 3,414 | 5.16 | 17,629 |
| 2024-01-17 | Hayden Jeremy B. (Chief Legal Officer) | Sale | 4,538 | 5.16 | 23,434 |
| 2023-12-27 | Sundheim Daniel S. | Sale | 2,852,036 | 5.86 | 16,712,930 |
| 2023-11-30 | Encrantz Staffan | Buy | 140,777 | 3.46 | 486,666 |
| 2023-11-29 | Encrantz Staffan | Buy | 3,223 | 3.50 | 11,280 |
| 2023-11-28 | Encrantz Staffan | Buy | 253,669 | 3.46 | 877,187 |
| 2023-11-27 | Encrantz Staffan | Buy | 246,331 | 3.31 | 815,848 |
| 2023-11-24 | Encrantz Staffan | Buy | 21,855 | 3.08 | 67,422 |
| 2023-11-24 | Badawi David (Chief Technology Officer) | Option Ex | 150,000 | .11 | 16,500 |
| 2023-11-22 | Encrantz Staffan | Buy | 41,085 | 2.50 | 102,712 |
| 2023-11-21 | Encrantz Staffan | Buy | 68,477 | 2.48 | 169,549 |
| 2023-11-20 | Encrantz Staffan | Buy | 79,234 | 2.25 | 178,197 |
| 2023-11-17 | Encrantz Staffan | Buy | 126,664 | 2.19 | 277,267 |
| 2023-11-16 | Encrantz Staffan | Buy | 339 | 2.00 | 678 |
| 2023-11-14 | Encrantz Staffan | Buy | 3,462 | 2.00 | 6,913 |
| 2023-09-14 | Park Sam Boong (Chief Operating Officer) | Option Ex | 37,668 | 1.96 | 73,829 |
| 2022-09-21 | Badawi David (Chief Technology Officer) | Option Ex | 40,000 | .23 | 9,200 |
| 2022-05-17 | Encrantz Staffan (Director) | Buy | 250,000 | 8.49 | 2,123,750 |
| 2022-05-16 | Encrantz Staffan (Director) | Buy | 300,000 | 8.20 | 2,460,000 |
| 2022-05-13 | Encrantz Staffan (Director) | Buy | 1,802 | 7.98 | 14,381 |
| 2022-05-13 | Selnick Jesse (Chief Financial Officer) | Buy | 5,000 | 8.28 | 41,400 |
| 2022-05-11 | Selnick Jesse (Chief Financial Officer) | Option Ex | 150,000 | .48 | 72,750 |
| 2022-03-25 | Park Sam Boong (Chief Operating Officer) | Option Ex | 3,666 | 1.96 | 7,185 |
| 2022-02-26 | Park Sam Boong (Chief Operating Officer) | Option Ex | 16,666 | 1.96 | 32,665 |
| 2021-12-01 | Encrantz Staffan (Director) | Buy | 214,606 | 22.24 | 4,772,193 |
| 2021-11-30 | Encrantz Staffan (Director) | Buy | 223,940 | 20.27 | 4,538,591 |
| 2021-11-29 | Encrantz Staffan (Director) | Buy | 86,454 | 18.95 | 1,638,303 |
| 2021-11-23 | Selnick Jesse (Chief Financial Officer) | Buy | 10,000 | 18.44 | 184,390 |
| 2021-10-18 | Encrantz Staffan (Director) | Buy | 527,048 | 24.00 | 12,649,152 |
| 2021-07-19 | Sundheim Daniel S. | Buy | 700,000 | 24.00 | 16,800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGHT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sight Sciences, Inc. (symbol SGHT, CIK number 1531177) see the Securities and Exchange Commission (SEC) website.